Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation
Affected assets and topics
REVENUE
Why it matters
Merck's Gardasil HPV vaccine sales may decline due to the CDC's revised recommendation of a single dose, potentially resulting in a loss of up to $630 million in revenue.
Article tone
Neutral
How the article is written, as reported by the source.
Expected market reaction
Market impact analysis based on bearish sentiment with 80% confidence.
Evidence trail
Evidence
Source
MarketWatch
Claim
Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation
AI inference
Bearish · 80%
Generated
2026-01-07 17:36
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 29792
Original source
The U.S. now only recommends one dose of an HPV vaccine. It used to say all children should get two to three doses of the vaccine, depending on their age.
Read the full article on MarketWatch
Original article published by MarketWatch on January 7, 2026. Analysis and insights provided by AnalystMarkets AI.